Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other 1Gynecologic 1

Conditions

Unspecified Adult Solid Tumor 1Solid Tumors 1Obesity 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Gliosarcoma 1Glioma 1Glioblastoma 1Endometrial Neoplasms 1Disease 1Diffuse Intrinsic Pontine Glioma 1Carcinosarcoma 1

Interventions

Metformin 2rosiglitazone-metformin combination 1mirabegron 1exemestane 1atezolizumab 1Tirzepatide 1TIC10 compound 1Rosiglitazone 1Hydroquinones 1Fish Oils 1Docosahexaenoic Acids 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Obesity × TIC10 compound × Clear all
NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
58 enrolled
GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡